MUR
52
3
XRAY
34
2
CAT
69
7
KMI
57
-2
PGR
65
-3
BAC
47
8
AEE
58
-3
LB
45
4
NDAQ
63
4
PNR
75
3
VMC
60
-3
RF
53
3
IR
77
8
MRK
50
-3
HOG
44
2
R
70
4
GRMN
52
2
AMG
44
3
MCO
78
3
WFC
61
3
MUR
52
3
XRAY
34
2
CAT
69
7
KMI
57
-2
PGR
65
-3
BAC
47
8
AEE
58
-3
LB
45
4
NDAQ
63
4
PNR
75
3
VMC
60
-3
RF
53
3
IR
77
8
MRK
50
-3
HOG
44
2
R
70
4
GRMN
52
2
AMG
44
3
MCO
78
3
WFC
61
3
Financhill
Back

Cellectar Biosciences Vs. Actinium Pharmaceuticals Industry Stock Comparison

Sell
44

CLRB
Cellectar Biosciences

Last Price:
2.06
Seasonality Move:
-15.64%
Sell
25

ATNM
Actinium Pharmaceuticals

Last Price:
1.80
Seasonality Move:
4.44%
Sell
44
Cellectar Biosciences (CLRB) is a Sell

Is Cellectar Biosciences a Buy, Sell or Hold?

  • The current Cellectar Biosciences [CLRB] share price is $2.11. The Score for CLRB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • CLRB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Actinium Pharmaceuticals (ATNM) is a Sell

Is Actinium Pharmaceuticals a Buy, Sell or Hold?

  • The current Actinium Pharmaceuticals [ATNM] share price is $1.88. The Score for ATNM is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • ATNM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLRB Stock Price Chart

What is Cellectar Biosciences's stock price today?

  • The Cellectar Biosciences share price today is $2.11
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing selling pressure, which indicates risk of future bearish movement.

ATNM Stock Price Chart

What is Actinium Pharmaceuticals's stock price today?

  • The Actinium Pharmaceuticals share price today is $1.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATNM is experiencing slight buying pressure.

CLRB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 47.36 Sell
Chaikin Money Flow: -173871 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.07 - 2.17) Sell
Bollinger Bands (100): (2.1 - 3.08) Sell

ATNM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 34.28 Sell
Chaikin Money Flow: 63209 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.8 - 2.04) Sell
Bollinger Bands (100): (3.1 - 8.84) Sell

CLRB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.11 Buy
20-day SMA: 2.13 Sell
50-day SMA: 2.19 Sell
200-day SMA: 2.99 Sell
8-day EMA: 2.11 Buy
20-day EMA: 2.12 Sell
50-day EMA: 2.24 Sell
200-day EMA: 2.67 Sell

ATNM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.86 Buy
20-day SMA: 1.89 Sell
50-day SMA: 3.81 Sell
200-day SMA: 6.24 Sell
8-day EMA: 1.85 Buy
20-day EMA: 2.08 Sell
50-day EMA: 3.43 Sell
200-day EMA: 5.82 Sell

Cellectar Biosciences Earnings Growth & CLRB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.02 per share, an increase this year of $1.08 per share, and an increase next year of $1.21 per share.

Actinium Pharmaceuticals Earnings Growth & ATNM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.09 per share, an increase this year of $0.62 per share, and an increase next year of $0.66 per share.

Cellectar Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Actinium Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):